Amarin Neuroscience Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Employees
- 11
- Market Cap
- -
- Website
- http://www.laxdale.co.uk
TREND-HD - A Trial of Ethyl-EPA (Miraxionâ„¢) in Treating Mild to Moderate Huntington's Disease
Phase 3
Completed
- Conditions
- Huntington Disease
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2007-12-27
- Lead Sponsor
- Amarin Neuroscience Ltd
- Target Recruit Count
- 300
- Registration Number
- NCT00146211
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath